This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objectives of this project are to evaluate the roles of DNA double strand break repair in normal hematopoietic cells and microenvironments, and to assess whether specific cell types in the bone marrow niche relate to tumorigenesis. Nonhomologous end joining (NHEJ), a critical DSB repair pathway, is an important suppressor of oncogenic genome instability in developing lymphocytes. New reports now also point to a role for DSB repair in maintaining stem cell function over time, and we have recently shown that NHEJ is an important suppressor of tumorigenesis in non-lymphoid tissues. Using mice deficient for the NHEJ factor ARTEMIS and for the tumor suppressor p53, we will test our hypotheses: 1) that the NHEJ pathway is critical for the fitness and function of normal hematopoietic cells, and 2) that bone marrow and lymphoid microenvironments are key determinants of pre-B cell leukemogenesis and lymphomagenesis.
Aim 1. To evaluate the extent to which NHEJ is required for normal function or homeostasis of cells in the hematopoietic compartment, we will: 1.1. measure HSC-derived cell populations in bone marrow and in circulation, and test whether NHEJ-deficient HSCs show defects in differentiation or fitness 1.2. assess genome instability in NHEJ-deficient stem and progenitor cell populations Aim 2. To determine whether specific stem cell or lymphoid microenvironments participate in shaping lymphoma phenotype, we will: 2.1. determine whether tumor latency, homing potential, or molecular etiology is differentially influenced by lympho-competent versus lympho-deficient bone marrow microenvironments 2.2. test whether tumor cells become adapted to specific secondary lymphoid microenvironments

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR018789-07
Application #
7960396
Study Section
Special Emphasis Panel (ZRR1-RI-6 (01))
Project Start
2009-06-01
Project End
2010-05-31
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
7
Fiscal Year
2009
Total Cost
$243,975
Indirect Cost
Name
Maine Medical Center
Department
Type
DUNS #
071732663
City
Portland
State
ME
Country
United States
Zip Code
04102
Duarte, Christine W; Black, Adam W; Lucas, F Lee et al. (2017) Cancer incidence in patients with hereditary hemorrhagic telangiectasia. J Cancer Res Clin Oncol 143:209-214
Caron, Jennifer M; Ames, Jacquelyn J; Contois, Liangru et al. (2016) Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope. Am J Pathol 186:1649-61
Stohn, J Patrizia; Wang, Qiaozeng; Siviski, Matthew E et al. (2015) Cthrc1 controls adipose tissue formation, body composition, and physical activity. Obesity (Silver Spring) 23:1633-42
Ufkin, Melanie L; Peterson, Sarah; Yang, Xuehui et al. (2014) miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leuk Res 38:402-10
He, Qing; Yang, Xuehui; Gong, Yan et al. (2014) Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity. J Bone Miner Res 29:1217-31
Motyl, Katherine J; Bishop, Kathleen A; DeMambro, Victoria E et al. (2013) Altered thermogenesis and impaired bone remodeling in Misty mice. J Bone Miner Res 28:1885-97
Yoon, Jeong Kyo; Lee, Jin-Seon (2012) Cellular signaling and biological functions of R-spondins. Cell Signal 24:369-77
Favreau, Amanda J; Sathyanarayana, Pradeep (2012) miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia. Leuk Res 36:334-41
Urs, Sumithra; Henderson, Terry; Le, Phuong et al. (2012) Tissue-specific expression of Sprouty1 in mice protects against high-fat diet-induced fat accumulation, bone loss and metabolic dysfunction. Br J Nutr 108:1025-33
Sathyanarayana, Pradeep; Dev, Arvind; Pradeep, Anamika et al. (2012) Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2. Blood 119:5522-31

Showing the most recent 10 out of 102 publications